Medicare to cover Medtronic hypertension treatment, unlocking big revenue potential
Executives at the Minnesota-run medtech giant have banked on the high blood pressure-curbing renal denervation system to boost its sluggish stock price.
More from Minnesota Business
Star Tribune Business
War made planting difficult. Now it could boost farmers' profits.
Minnesota Business
•
21h ago
Star Tribune Business
Ramstad: Fraud in Minnesota has not cost $9 billion, but it's hurt more
Minnesota Business
•
1d ago
Star Tribune Business
Summit Brewing could avoid foreclosure with new lender
Minnesota Business
•
3d ago
Star Tribune Business
Watch the replays of the North Star Summit sessions
Minnesota Business
•
3d ago